首页 | 本学科首页   官方微博 | 高级检索  
检索        

福州市2016-2020年耐药肺结核发现情况分析
引用本文:李佳,黄玲,赵玉杭,羊晶晶.福州市2016-2020年耐药肺结核发现情况分析[J].中国热带医学,2021,21(8):795-799.
作者姓名:李佳  黄玲  赵玉杭  羊晶晶
作者单位:福州市疾病预防控制中心,福建 福州 350004
摘    要:目的 通过分析福州市2016-2020年报告的肺结核耐药筛查情况,为制定符合当地情况的耐药结核防控措施提供科学依据。方法 收集2016-2020年在《中国疾病预防控制信息系统结核病管理信息系统》中登记的耐药可疑者信息资料,对耐药肺结核和耐多药肺结核筛检情况、分布特征进行分析。结果 2016-2020年福州市报告耐药可疑者7 381例,耐药筛查3 805例,筛查率为51.55%。检出耐药患者492例,检出率为12.93%,其中耐多药患者229例,耐多药检出率为6.02%。新病原学阳性和高危人群耐药检出率分别为10.86%(308/2 835)和18.97%(184/970),差异有统计学意义(P<0.01);新病原学阳性和高危人群耐多药检出率分别为4.16%(118/2 835)和11.44%(111/970),差异有统计学意义(P<0.01)。男性耐药和耐多药检出率分别为13.01%(355/2 729)和5.94%(162/2 729),与女性的12.73%(137/ 1 076)和6.23%(67/1 076)比较,差异无统计学意义(P>0.05)。40~<50岁年龄组耐药检出率为16.96%和海员及长途驾驶员(40.00%)、教师(25.00%)以及商业服务人员(22.58%)等三种职业人群耐药检出率最高。结论 福州市2016-2020年耐药肺结核防治工作取得一定成效,要针对重点人群加强健康教育工作,加大治疗管理力度,提高筛查手段。

关 键 词:结核    新病原学阳性患者  高危人群患者  耐药  耐多药  检出率  
收稿时间:2021-04-16

Analysis of drug-resistant pulmonary tuberculosis in Fuzhou, 2016- 2020
LI Jia,HUANG Ling,ZHAO Yu-hang,YANG Jing-jing.Analysis of drug-resistant pulmonary tuberculosis in Fuzhou, 2016- 2020[J].China Tropical Medicine,2021,21(8):795-799.
Authors:LI Jia  HUANG Ling  ZHAO Yu-hang  YANG Jing-jing
Institution:Fuzhou Center for Disease Control and Prevention, Fuzhou, Fujian 350004, China
Abstract:Objective To provide a scientific basis for the development of drug-resistant tuberculosis prevention and control measures in line with the local situation, by analyzing the drug-resistant screening of tuberculosis reported in Fuzhou from 2016 to 2020. Methods Data of drug-resistant suspects registered in the tuberculosis information management system of China Disease Control and prevention information system from 2016 to 2020 were collected. Results From 2016 to 2020, 7 381 cases of suspected drug resistance were reported in Fuzhou, and 3 805 cases were screened for drug resistance, with a screening rate of 51.55%. 492 drug resistant patients were detected, the detection rate was 12.93%, among them, there were 229 multiple drug resistance (MDR) patients, and the detection rate of MDR was 6.02%. There was a significant difference in the detection rate of drug resistance between new etiologic positive patients 10.86% (308/2 835) and high-risk groups 18.9% (184/970) (P<0.01); there was a significant difference in the detection rate of MDR between new etiologic positive patients 4.16% (118/2 835) and high-risk groups 11.44% (111/970) (P<0.01). There was no significant difference in the detection rate of drug resistance and the rate of MDR in different genders, male 13.01% (355/2 729) and 5.94% (162/2 729) (P>0.05), female 12.73% (137/1 076) and 6.23% (67/1 076). The detection rate of drug resistance was the highest in 40-<50 age group. The detection rate of drug resistance was the highest in seamen and long-distance drivers (40.00%), teachers (25.00%) and business service personnel (22.58%). Conclusion The prevention and treatment of drug-resistant tuberculosis in Fuzhou City from 2016 to 2020 has achieved certain results. It is necessary to strengthen health education for key groups, and improve screening methods.
Keywords:Pulmonary tuberculosis  new pathogen positive  high risk population  resistant  multidrug resistant  detection rate  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国热带医学》浏览原始摘要信息
点击此处可从《中国热带医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号